Europe fears being left out in international QS (quality system) standard revision
This article was originally published in Clinica
Opposition by a minority in Europe to the revision of the most fundamental international medical device standard, ISO 13485, on medical device quality systems, threatens to put European manufacturers at a disadvantage compared with manufacturers elsewhere in the world, Clinica has learnt.
You may also be interested in...
Cilta-cel maintained high response rates in longer-term multiple myeloma data, but ide-cel causes less cytokine release syndrome and severe neurotoxicity – and it has a March decision date at the US FDA.
Our updated graphic tracker of key developments from the leading vaccine candidates.
Pathway open for drug as post-covalent BTK option as Loxo gears up for "risky" Phase III head-to-head study in Q1 2021.